Pantoxon (Ceftriaxone Disodium Salt Hemiheptahydrate)

Ceftriaxone, the active ingredient in Pantoxon, is a cephalosporin presented as an injectable solution for intravenous use. It treats a range of serious bacterial infections in adults and children. GNH USA supplies Pantoxon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Pantoxon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pantoxon is a broad‑spectrum cephalosporin antibiotic that acts on bacterial infections of several organ systems.

- Community‑acquired pneumonia: helps resolve pulmonary infection and improve breathing function. - Meningitis: penetrates the cerebrospinal fluid to eradicate the causative bacteria. - Gonorrhea: eliminates Neisseria gonorrhoeae and reduces transmission risk. - Urinary tract infections: clears urinary pathogens and relieves symptoms. - Skin and soft‑tissue infections: treats cellulitis and related bacterial skin conditions.

Adverse reactions to ceftriaxone may vary in frequency and severity.

Common Side Effects: - Injection site pain or erythema - Diarrhea or loose stools - Nausea or mild vomiting - Transient elevation of liver enzymes - Rash or mild itching - Headache

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema) - Clostridioides difficile‑associated colitis - Hemolytic anemia or eosinophilic pneumonia - Hepatotoxicity with jaundice - Renal impairment or acute kidney injury - Blood clotting abnormalities (e.g., disseminated intravascular coagulation).

Ceftriaxone should be used with caution in specific clinical situations.

- Renal impairment: adjust monitoring and consider alternative agents. - Hepatic dysfunction: monitor liver function tests during therapy. - Neonates and infants <28 days: avoid intravascular use due to risk of bilirubin displacement. - Calcium-containing solutions: do not mix; risk of precipitation. - Known hypersensitivity to cephalosporins or penicillins: avoid use. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Ceftriaxone may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Calcium‑containing IV solutions: can precipitate, leading to embolic events. - Biliary‑excreted drugs (e.g., warfarin): may increase anticoagulant effect.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: may enhance renal clearance of ceftriaxone. - Oral contraceptives: possible reduction in contraceptive efficacy; advise backup method. - Antacids containing aluminum or magnesium: may affect absorption if given intramuscularly. - Probenecid: reduces renal excretion, increasing ceftriaxone levels.